4 Likes
That sounds promising. It’d be great to see doctors prescribing something to counteract weight gain in the future.
1 Like
“This finding is clinically significant because of an FDA-approved weight loss drug called lorcaserin, which in contrast to olanzapine, activates the serotonin 2c receptor. Based on the opposite effects of lorcaserin and olanzapine on the serotonin 2c receptor, we wanted to test whether lorcaserin treatment could counteract the metabolic effects of olanzapine. Co-treating with lorcaserin prevented weight gain and significantly improved the metabolic profile of mice treated with olanzapine,” he said"
Wonder how long it will take to catch on, since it’s an already approved drug
2 Likes